by EPHA | Feb 3, 2010 | Opinion
The Employment, Social Policy, Health and Consumer Affairs Council meeting took place on 1 December 2009 in Brussels. A summary of its conclusions on eHealth is available here. The Council began its conclusions with a summary of previous actions in the field of... by EPHA | Mar 6, 2009 | Opinion
Trade negotiations between the EU and the Community of Andean Nations potentially threaten access to cheaper medicines with the EU calling for strict measures to protect intellectual property. EPHA, Health Action International and Doctors without boarders (MSF) have... by EPHA | Feb 5, 2009 | Opinion
Health Action International (HAI) is an independent, global network working to increase access to essential medicines and improve their rational use through research excellence and evidence-based advocacy. In cooperation with the EU Policy Coherence for Development... by EPHA | Jun 1, 2008 | Opinion
European antitrust investigators are expanding the scope of a major inquiry into the €484 billion pharmaceutical market in a bid to determine whether companies are blocking generics makers from getting less-expensive medicines to market quickly. Neelie Kroes, the...
